Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Hammond

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003)Christine H Chung, James J Dignam, M Elizabeth Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02Li-Yan Khor, Kyounghwa Bae, Rebecca Paulus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused UpdateIan Krop, Nofisat Ismaila, Fabrice Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2019
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORxFabrice Andre, Nofisat Ismaila, N Lynn Henry, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2011
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncologyPhillip G Febbo, Marc Ladanyi, Kenneth D Aldape, et al.
Archives of Pathology & Laboratory Medicine|January 16, 2019
Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American PathologistsMarilyn M Bui, Michael W Riben, Kimberly H Allison, et al.
Clinical Chemistry|July 9, 2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirementsCatharine M Sturgeon, Barry R Hoffman, Daniel W Chan, et al.
NIH Consensus and State-Of-The-Science Statements|February 9, 2013
NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancerPatricia A Ganz, John M Barry, Wylie Burke, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by ImmunohistochemistryD Craig Allred, Robert W Carlson, Donald A Berry, et al.
The Annals of Thoracic Surgery|September 28, 2011
Allograft rejection in patients supported with continuous-flow left ventricular assist devicesAaron H Healy, Nathan O Mason, M Elizabeth Hammond, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2011
Glioma-associated oncogene family zinc finger 1 expression and metastasis in patients with head and neck squamous cell carcinoma treated with radiation therapy (RTOG 9003)Christine H Chung, James J Dignam, M Elizabeth Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02Li-Yan Khor, Kyounghwa Bae, Rebecca Paulus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2017
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused UpdateIan Krop, Nofisat Ismaila, Fabrice Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2019
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORxFabrice Andre, Nofisat Ismaila, N Lynn Henry, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2011
NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncologyPhillip G Febbo, Marc Ladanyi, Kenneth D Aldape, et al.
Archives of Pathology & Laboratory Medicine|January 16, 2019
Quantitative Image Analysis of Human Epidermal Growth Factor Receptor 2 Immunohistochemistry for Breast Cancer: Guideline From the College of American PathologistsMarilyn M Bui, Michael W Riben, Kimberly H Allison, et al.
Clinical Chemistry|July 9, 2008
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirementsCatharine M Sturgeon, Barry R Hoffman, Daniel W Chan, et al.
NIH Consensus and State-Of-The-Science Statements|February 9, 2013
NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancerPatricia A Ganz, John M Barry, Wylie Burke, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 17, 2009
NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by ImmunohistochemistryD Craig Allred, Robert W Carlson, Donald A Berry, et al.
The Annals of Thoracic Surgery|September 28, 2011
Allograft rejection in patients supported with continuous-flow left ventricular assist devicesAaron H Healy, Nathan O Mason, M Elizabeth Hammond, et al.
Pageof 6